Illumina Inc (NASDAQ:ILMN)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.


Player Avatar Raphael1990 (86.57) Submitted: 2/24/2013 12:28:15 PM : Underperform Start Price: $49.03 ILMN Score: -207.55

Takeover is off the table for now, but the valuation is still too high given the fundamentals.

Featured Broker Partners